Strs Ohio trimmed its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 10.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 45,787 shares of the insurance provider’s stock after selling 5,605 shares during the period. Strs Ohio’s holdings in Humana were worth $7,939,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently bought and sold shares of HUM. Montag A & Associates Inc. grew its stake in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC lifted its position in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac acquired a new stake in shares of Humana during the fourth quarter worth approximately $27,000. Reflection Asset Management purchased a new position in Humana during the fourth quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton grew its position in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the stock. Guggenheim increased their target price on shares of Humana from $252.00 to $269.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Leerink Partners upped their price target on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research note on Thursday, April 30th. Barclays increased their price objective on Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 26th. Royal Bank Of Canada reissued a “sector perform” rating on shares of Humana in a research report on Monday, June 1st. Finally, Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $293.09.
Humana Stock Down 0.1%
HUM stock opened at $396.38 on Monday. The firm has a market cap of $47.59 billion, a PE ratio of 42.39, a PEG ratio of 2.26 and a beta of 0.71. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $415.00. The company has a fifty day simple moving average of $321.87 and a 200 day simple moving average of $250.40. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.
Humana (NYSE:HUM – Get Free Report) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period in the prior year, the business posted $11.58 earnings per share. The business’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts anticipate that Humana Inc. will post 9.03 EPS for the current fiscal year.
Humana Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s dividend payout ratio is currently 37.86%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
See Also
- Five stocks we like better than Humana
- Visa’s Open USD Push Puts Circle’s Stablecoin Moat Under Pressure
- This Under-the-Radar Industrial Is Quietly Powering AI
- Why Microsoft Looks Like the Best Big Tech Trade for H2 2026
- Strategy’s Bitcoin Pivot Gives Investors a New Reason to Watch Preferred Shares
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
